Skip to content

Samplix vs Sutro Biopharma, Inc.

Samplix logo

Samplix

Reveal cell function with single-cell resolution

35 employees · est. 2013 · Denmark

VS
Sutro Biopharma, Inc. logo

Sutro Biopharma, Inc.

Changing the future of Oncology

208 employees · est. 2003 · South San Francisco, United...

Sutro Biopharma, Inc. is the older company (2013 vs 2003); Sutro Biopharma, Inc. is the larger of the two.

Side-by-Side Comparison

Samplix Sutro Biopharma, Inc.
Founded
2013 2003 older
Headquarters
Denmark South San Francisco, United States
Employees
35 208 larger
Industry
Biotechnology, Information Technology Biotechnology, Information Technology
Funding Stage
Venture round IPO
Total Funding
$12.67M $745.90M
Funding Rounds
3 12
Services
Not tracked yet Development of single- and dual-payload ADCs, Oncology research and therapeutics, Scientific and clinical advisory services
Target Customers
Not tracked yet Cancer patients, Healthcare providers, Biopharmaceutical investors, Scientific community
Taxonomy
Single-cell AnalysisImmunotherapy ResearchDouble Emulsion TechnologyFlow CytometryCell SortingXdrop Technology +9 Oncology TherapeuticsCancer TreatmentAntibody Drug ConjugatesExatecanProtein EngineeringBiopharmaceutical Development +9
Website
samplix.com sutrobio.com
Samplix logo

About Samplix

Samplix is a Denmark-based biotechnology startup founded in 2013 with a focus on single-cell analysis in immunotherapy research. The company's flagship product, Xdrop, utilizes double emulsion technology to encapsulate living cells and reactive molecules in stable droplets, enabling rapid cell-cell...

Sutro Biopharma, Inc. logo

About Sutro Biopharma, Inc.

Sutro Biopharma, Inc. is a pioneering player in the oncology sector, driven by its commitment to transform cancer treatment. The company, with the slogan "Changing the future of Oncology," leverages its proprietary XpressCF® technology to develop precisely designed cancer therapeutics, aiming to gre...

Also comparing in this category

Comparing more than these two?

Get Samplix, Sutro Biopharma, Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Samplix compare?

A PDF of Samplix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Samplix was founded in 2013, based in Denmark, with 35 employees. Samplix is a Denmark-based biotechnology startup founded in 2013 with a focus on single-cell analysis in immunotherapy research. The company's flagship product, Xdrop, utilizes double emulsion technol. Sutro Biopharma, Inc. was founded in 2003, based in South San Francisco, United States, with 208 employees. Sutro Biopharma, Inc. is a pioneering player in the oncology sector, driven by its commitment to transform cancer treatment. The company, with the slogan "Changing the future of Oncology," leverages i.
Samplix has raised $12.67M and Sutro Biopharma, Inc. $745.90M. Latest stage: Samplix Venture round, Sutro Biopharma, Inc. IPO.
Both work in Biotechnology and Information Technology and list protein engineering among their focus areas.

Compare Samplix with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Samplix on 12 Sep 2024, and Sutro Biopharma, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout